M&A Deal Summary |
|
---|---|
Date | 2018-10-18 |
Target | MPX Bioceutical |
Sector | Consumer Products |
Buyer(s) | iAnthus |
Deal Type | Merger |
Deal Value | 835M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Sector | Consumer Products |
Employees | 717 |
Revenue | 159M USD (2023) |
iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and health care services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. iAnthus is based in New York City.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Consumer Products) | 1 of 3 |
Type (Merger) | 1 of 1 |
State (Ontario) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2018) | 1 of 1 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-03-29 |
CBD for Life
Owensboro, Kentucky, United States CBD For Life produces highly innovative, natural, luxurious, and effective Cannabidiol (CBD) infused pain management and beauty products using 99% pure CBD extract derived from stems and stalks of industrial hemp. Our revolutionary formulas combine CBD with nourishing essential oils and other active ingredients to aid in reducing pain, inflammation, and stress while promoting anti-aging, rejuvenation, and vibrancy. |
Buy | $16M |